Direct-to-consumer Disease Risk and Health Test market

Direct-to-consumer Disease Risk and Health Test Market, Global Outlook and Forecast 2022-2028

  • 27 July 2022
  • Life Sciences
  • 110 Pages
  • Report code : PMR-7235401

  • 4.7 (158)

Direct-to-consumer Disease Risk and Health Test Market

Download FREE Report Sample

  Download Free sample

The results of these tests estimate your genetic risk of developing several common diseases, such as?celiac disease,?Parkinson disease, and?Alzheimer disease. Some companies also include a person?s carrier status for less common conditions, including?cystic fibrosis?and?sickle cell disease. A carrier is someone who has one copy of a gene mutation that, when present in two copies, causes a genetic disorder.

Direct-to-consumer Disease Risk and Health Test Market contains market size and forecasts of Direct-to-consumer Disease Risk and Health Test in Global, including the following market information:

Global Direct-to-consumer Disease Risk and Health Test Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Direct-to-consumer Disease Risk and Health Test market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Celiac Disease Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Direct-to-consumer Disease Risk and Health Test include 23andMe, MyHeritage, LabCorp, Myriad Genetics, Ancestry.com, Quest Diagnostics, Gene By Gene, DNA Diagnostics Center and Invitae, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Direct-to-consumer Disease Risk and Health Test companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Direct-to-consumer Disease Risk and Health Test Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Direct-to-consumer Disease Risk and Health Test Market Segment Percentages, by Type, 2021 (%)

Celiac Disease

Parkinson Disease

Alzheimer Disease

Other

Global Direct-to-consumer Disease Risk and Health Test Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Direct-to-consumer Disease Risk and Health Test Market Segment Percentages, by Application, 2021 (%)

Online

Offline

Global Direct-to-consumer Disease Risk and Health Test Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Direct-to-consumer Disease Risk and Health Test Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Direct-to-consumer Disease Risk and Health Test revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Direct-to-consumer Disease Risk and Health Test revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

23andMe

MyHeritage

LabCorp

Myriad Genetics

Ancestry.com

Quest Diagnostics

Gene By Gene

DNA Diagnostics Center

Invitae

IntelliGenetics

Ambry Genetics

Living DNA

EasyDNA

Pathway Genomics

Centrillion Technology

Xcode

Color Genomics

Anglia DNA Services

African Ancestry

Canadian DNA Services

DNA Family Check

Alpha Biolaboratories

Test Me DNA

23 Mofang

Genetic Health

DNA Services of America

Shuwen Health Sciences

Mapmygenome

Full Genomes

CHECK TODAYS BEST PRICE

BEST PRICE: $2275
Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Direct-to-consumer Disease Risk and Health Test Market

Leave This Empty: